Akero Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2019 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Akero Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2019 to Q3 2024.
  • Akero Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 69.8M shares, a 25.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 69.8M +14.1M +25.3% Oct 31, 2024 10-Q 2024-11-08
Q2 2024 69.4M +13.8M +24.9% Aug 2, 2024 10-Q 2024-08-09
Q1 2024 69.2M +22.2M +47.2% May 3, 2024 10-Q 2024-05-10
Q3 2023 55.7M +8.95M +19.1% Nov 3, 2023 10-Q 2023-11-13
Q2 2023 55.6M +18M +48% Aug 4, 2023 10-Q 2023-08-11
Q1 2023 47M +11.9M +34.1% Mar 14, 2023 10-K 2023-03-17
Q3 2022 46.8M +11.9M +34% Oct 28, 2022 10-Q 2022-11-04
Q2 2022 37.6M +2.71M +7.77% Jul 29, 2022 10-Q 2022-08-05
Q1 2022 35M +253K +0.73% Apr 29, 2022 10-Q 2022-05-06
Q3 2021 34.9M +166K +0.48% Nov 9, 2021 10-Q 2021-11-12
Q2 2021 34.9M +161K +0.46% Aug 8, 2021 10-Q 2021-08-13
Q1 2021 34.8M +6.16M +21.5% Mar 10, 2021 10-K 2021-03-16
Q3 2020 34.7M +6.16M +21.6% Nov 6, 2020 10-Q 2020-11-12
Q2 2020 34.7M +6.15M +21.5% Aug 7, 2020 10-Q 2020-08-12
Q1 2020 28.6M Mar 6, 2020 10-K 2020-03-16
Q3 2019 28.6M Nov 8, 2019 10-Q 2019-11-12
Q2 2019 28.6M Aug 12, 2019 10-Q 2019-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.